News
-
-
-
COMMUNIQUÉ DE PRESSE
vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay
vVARDIS secures $35 million financing from OrbiMed to expand global commercial reach with innovative drill-free treatment for early tooth decay under Curodont brand